NCT01840540View on ClinicalTrials.gov

MSC for Occlusive Disease of the Kidney

PHASE1CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

March 31, 2014

Study Completion Date

April 30, 2017

Conditions

Atherosclerotic Renal Artery StenosisIschemic NephropathyRenovascular Hypertension

Interventions

DRUG

Arterial infusion of autologous mesenchymal stem cells

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER

NCT01840540 - MSC for Occlusive Disease of the Kidney | Biotech Hunter | Biotech Hunter